5 Pilot of a Modified HEART Score and Serial High Sensitivity Troponin T Pathway to Reduce Chest Pain Observations

Recent innovations have led to markedly decreased admission rates and reductions in 30-day major adverse cardiac event (MACE) rates to 0.5% in Europe, which is improved over previous U.S. national estimated rates of missed acute myocardial infarction (2.1%) and unstable angina (2.3%). High sensitivity troponin T (hs-TnT) has recently been approved by the FDA. Our objective is to decrease "nonproductive" chest pain observations by reducing variability in assessments of patients presenting to the emergency department (ED) with chest pain (or other potentially ischemic symptoms), through the use of a modified HEART score and serial hs-TnT measurements at 0 and 1 hour, while simultaneously maintaining or improving patient outcomes.

http://ift.tt/2xbDBre